A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study

Phase 2

Terminated

• Conditions: Anorexia Nervosa

• Registration Number: NCT00584688
• Lead Sponsor: University of South Florida

Brief Summary

Research studies raise the possibility that medications such as quetiapine may improve mood or reduce obsessions in people with anorexia nervosa and may even help to normalize appetite. The medication quetiapine also known as seroquel works by activating certain systems in the brain, such as ones known as dopamine and serotonin chemical systems in the brain.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-02
• Study First Submitted: 2007-12-21
• Study First Submitted QC: 2007-12-31
• Study First Posted: 2008-01-02
• Status Verified: 2009-03
• Primary Completion: 2009-06
• Study Completion: 2009-08
• Last Update Submitted: 2012-06-14
• Last Update Posted: 2012-06-18

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• Must be aged 18-65
• Must be at least 15% below ideal body weight

Exclusion Criteria

• Allergy to quetiapine
• Diagnosis of schizophrenia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
To determine efficacy of seroquel in anorexia nervosa	8 weeks

Trial Locations

Locations (1)

University of South Floirda; 🇺🇸 Tampa, Florida, United States